The pneumococcal vaccine Vaxneuvance, which can now be received free of charge in Korea, is quickly landing in general hospitals in Korea.

According to industry sources, MSD’s vaccine has passed the drug committees (DCs) of the ‘Big 5’ tertiary hospitals in Korea, including Samsung Medical Center, Seoul National University Hospital, Seoul St. Mary's Hospital, Seoul Asan Medical Center, and Sinchon Severance Hospital.

It is also being rapidly supplied to local clinic-level institutions as well.

Vaxneuvance, which has been included in the National Immunization Program (NIP) since January 1, is used to prevent invasive diseases and pneumonia caused by a total of 15 pneumon